Researchers Develop Low-Cost Novel Coronavirus Test

Researchers Develop Low-Cost Novel Coronavirus Test

  • Research Stash
  • News
  • 1.4K

The Indian Council of Medical Research (ICMR) has recommended only a reverse transcription-polymerase chain reaction (RT-qPCR) test for novel coronavirus testing. Researchers at the Centre for Cellular and Molecular Biology (CCMB) have developed a new low-cost and low-tech required test for SARS-CoV-2 testing. This test is known as reverse transcription nested PCR (RT-nPCR) test.

Researchers Develop Low-Cost Novel Coronavirus Test
Researchers Develop Low-Cost Novel Coronavirus Test

This test does not require real-time quantitative RT-qPCR. The RT-nPCR developed by the CCMB research team has shown comparable performance to the standard RT-qPCR test. The nested PCR (RT-nPCR) approach does not depend on RT-qPCR but uses standard RT-PCR as part of an endpoint assay.

In the course of comparing the results of both tests, researchers found that the standard RT-qPCR test can have low detection efficiency (less than 50%) in a real testing scenario, which may be due to low viral representation in many samples. This finding brought home the importance of monitoring detection efficiency directly in test environments.

“We developed and tested an RT-nPCR protocol comprising a multiplex primary RT-PCR for amplification of four SARS-CoV-2 amplicons and a control human amplicon followed by a secondary nested PCR for individual amplicons. We also examined the use of RT-nPCR in pooled testing and indirect amplification without RNA isolation,” said Dr. Rakesh Mishra, Director, CCMB, while speaking with India Science Wire.

The RNA isolated from nasopharyngeal swab samples that had been previously tested using one of the two RT-qPCR tests was examined using RT-nPCR and the results were compared. It was found that taking both standard RT-qPCR tests together, the RT-nPCR test was able to identify 90% of the detected samples as positive by RT-qPCR.

It also detected 13% samples as positive among samples that were negative by the standard RT-qPCR test (likely false negatives). Based on the experimentally measured false-negative rate by RT-nPCR tests from this study, it was estimated that as many as 50% of positive samples may escape detection in single pass testing by RT-qPCR in an actual testing scenario.

“This new test is awaiting approval from ICMR. We might ask ICMR to use this test in those places where there are no RT-qPCR machines,” remarked Dr. Mishra. (ISW)

Jyoti Singh

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

Rate

“We developed and tested an RT-nPCR protocol comprising a multiplex primary RT-PCR for amplification of four SARS-CoV-2 amplicons and a control human amplicon followed by a secondary nested PCR for individual amplicons. We also examined the use of RT-nPCR in pooled testing and indirect amplification without RNA isolation,” said Dr. Rakesh Mishra, Director, CCMB, while speaking with India Science Wire.

The RNA isolated from nasopharyngeal swab samples that had been previously tested using one of the two RT-qPCR tests was examined using RT-nPCR and the results were compared. It was found that taking both standard RT-qPCR tests together, the RT-nPCR test was able to identify 90% of the detected samples as positive by RT-qPCR.

It also detected 13% samples as positive among samples that were negative by the standard RT-qPCR test (likely false negatives). Based on the experimentally measured false-negative rate by RT-nPCR tests from this study, it was estimated that as many as 50% of positive samples may escape detection in single pass testing by RT-qPCR in an actual testing scenario.

“This new test is awaiting approval from ICMR. We might ask ICMR to use this test in those places where there are no RT-qPCR machines,” remarked Dr. Mishra. (ISW)

Jyoti Singh

If you liked this article, then please subscribe to our YouTube Channel for the latest Science & Tech news. You can also find us on Twitter & Facebook

" }
Electrostatic Disinfection Technology Transferred for Commercialization1

Electrostatic Disinfection Technology Transferred for Commercialization

CSIR-CSIO has designed and developed an innovative technology for effective disinfection and sanitization to fight with the corona pandemic.

  • News
  • 2.7K
Read more
Black Pepper May Hold the Key for Corona Fighting Drug

Black Pepper May Hold the Key for Corona Fighting Drug

A team of scientists has identified black pepper, the everyday kitchen spice, as a possible candidate for developing a drug against COVID-19

  • News
  • 1.3K
Read more
Scientists Provide New Insight into Bipolar Disorder

Scientists Provide New Insight into Bipolar Disorder

Researchers have found that bipolar disorder patients carry some residual impairment in terms of processing of information even in their ‘normal’ phases

  • News
  • 1.2K
Read more

Internet is huge! Help us find great content

Newsletter

Never miss a thing! Sign up for our newsletter to stay updated.

About

Research Stash is a curated collection of tools and News for S.T.E.M researchers

Have any questions or want to partner with us? Reach us at hello@researchstash.com

Navigation

Submit